Key Highlights
- Erik Ostrowski appointed as Senior VP, CFO, and CBO at Akebia Therapeutics.
- Experienced biotech executive with extensive industry leadership.
- Key role in Vafseo® (vadadustat) Tablets launch and corporate finance.
Source: PR Newswire
Notable Quotes
- “We are pleased to welcome Erik to Akebia as he brings proven leadership experience across a broad range of critical functions. He will be an important addition to our experienced leadership team.” — John P. Butler, CEO at Akebia Therapeutics
- “I am incredibly excited to join the Akebia team during this transformational time for the company.” — Erik Ostrowski, Senior VP, CFO, and CBO at Akebia Therapeutics
SoHC's Take
The appointment of Erik Ostrowski as Senior Vice President, Chief Financial Officer, and Chief Business Officer is a strategic move by Akebia Therapeutics. Ostrowski’s extensive experience in biotech leadership and investment banking positions him well to manage Akebia’s corporate finance and strategic development. His track record with Avrobio and Summit Therapeutics demonstrates his capability in driving corporate transactions and financial growth. As Akebia launches Vafseo® (vadadustat) Tablets, Ostrowski’s expertise will be pivotal in ensuring a successful product launch and sustained growth for the company.
